Protocol for a patient-derived preclinical platform to model tumor-immune interactions and evaluate therapeutic efficacy
Summary: Here, we present a protocol for a preclinical ex vivo platform combining experimental flexibility with preservation of the tumor microenvironment. We outline steps for isolating human peripheral blood mononuclear cells (PBMCs), preparing patient-derived precision-cut tumor slices (PCTSs), c...
Saved in:
Main Authors: | Wen-Hsin Chang, Andrew I. Chin, Ching-Hsien Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | STAR Protocols |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666166725000292 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protocol for assessing T cell receptor-mediated human T cell cytotoxicity
by: Kathryne E. Marks, et al.
Published: (2025-03-01) -
Protocol for assessing immune-target cell interactions using a single-cell cytotoxicity assay
by: Zhihao Wei, et al.
Published: (2025-03-01) -
HHV-6B ribonucleotide reductase sequesters NF-κB subunit p65 to inhibit innate immune responses
by: Mansaku Hirai, et al.
Published: (2025-02-01) -
The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19
by: Clara Hernández-Blanco, et al.
Published: (2025-02-01) -
Protocol for extracellular vesicle secretion-related gene screening via ExoScreen technique
by: Tomofumi Yamamoto, et al.
Published: (2025-03-01)